LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・Amgen Inc

Amgen Inc

Closed

Sector Healthcare

320.32 -1.06

Buy Sell

Overview

Share price change

24h

Current

Min

319.83

Max

321.91

Key metrics
By Trading Economics
Income	859M 746M
Sales	940M 8.4B
P/E Sector Avg	44.64 103.001
EPS	4.97
Profit margin	8.892
Employees	26,700
EBITDA	847M 3B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+4.61 upside

Dividends
By Dow Jones
Next Earnings	29 paź 2024
Next Dividend date	6 gru 2024
Next Ex Dividend date	14 lis 2024

Market Stats
By TradingEconomics
Market Cap	96M 179B
Previous open	321.38
Previous close	320.32

News Sentiment

By Acuity

53%

47%

282 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

N/A / 331.29 Support & Resistance

Amgen Inc Chart

Related News

6 sie 2024, 21:00 UTC

Earnings

Amgen 2Q Revenue Jumps, Profit Narrows on Higher Expenses

2 maj 2024, 20:42 UTC

Earnings

Amgen Posts Higher 1Q Revenue, Swings to Loss

3 wrz 2024, 04:00 UTC

Top News

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

7 sie 2024, 14:22 UTC

Top News

Earnings

It Isn't Time to Worry About Wegovy Yet -- Heard on the Street -- WSJ

7 sie 2024, 09:07 UTC

Earnings

Hot Stocks

Stocks to Watch Wednesday: Super Micro, Rivian, Airbnb -- WSJ

7 sie 2024, 08:55 UTC

Top News

These Stocks Are Moving the Most Today: Super Micro, Lumen, Airbnb, Rivian, Fortinet, Upstart, Disney, and More -- Barrons.com

6 sie 2024, 20:20 UTC

Earnings

Amgen Sees FY24 Share Repurchases Not Exceeding $500 M >AMGN

6 sie 2024, 20:20 UTC

Earnings

Amgen Sees FY24 Capital Expenditures About $1.3 B >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen 2Q EPS $1.38 >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen 2Q Adj EPS $4.97 >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen 2Q Worldwide Neulasta Sales $105M >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen 2Q Worldwide Prolia Sales $1.17B >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen Sees FY Adj EPS $19.10-Adj EPS $20.10 >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen 2Q Net $746M >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen 2Q Worldwide XGEVA Sales $562M >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen Sees FY EPS $6.57-EPS $7.62 >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen 2Q Rev $8.4B >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen 2Q Worldwide Enbrel Sales $909M >AMGN

6 sie 2024, 20:01 UTC

Earnings

Amgen Sees FY Rev $32.8B-$33.8B >AMGN

6 sie 2024, 08:45 UTC

Top News

Earnings

These Stocks Are Moving the Most Today: Palantir, Nvidia, Apple, Lumen, Lucid, Caterpillar, and More -- Barrons.com

19 lip 2024, 11:00 UTC

Top News

Rivals Emerge to Ozempic and Zepbound -- but With a Lag -- Heard on the Street -- WSJ

19 cze 2024, 05:30 UTC

Top News

Acquisitions, Mergers, Takeovers

M&A Is Back. 4 Stocks That Could Be Targets. -- Barrons.com

3 maj 2024, 14:43 UTC

Hot Stocks

Stocks to Watch Friday: Apple, Amgen, Exxon, Coinbase -- WSJ

3 maj 2024, 11:43 UTC

Market Talk

Earnings

Amgen's Weight-Loss Drug Prospects Win New Bull -- Market Talk

3 maj 2024, 08:45 UTC

Earnings

Hot Stocks

Stocks to Watch Friday: Apple, Amgen, Block -- WSJ

3 maj 2024, 08:28 UTC

Earnings

These Stocks Are Moving the Most Today: Apple, Amgen, Expedia, Block, Coinbase, Cloudflare, Fortinet, and More -- Barrons.com

2 maj 2024, 20:04 UTC

Earnings

Amgen: FY Share Repurchases Not to Exceed $500 M >AMGN

2 maj 2024, 20:04 UTC

Earnings

Amgen Sees FY Capital Expenditure About $1.1B >AMGN

2 maj 2024, 20:03 UTC

Earnings

Amgen 1Q Adj EPS $3.96 >AMGN

2 maj 2024, 20:01 UTC

Earnings

Amgen 1Q Worldwide Enbrel Sales $567M >AMGN

Peer Comparison

Price change

Amgen Inc Forecast

Price Target

By TipRanks

4.61% upside

12 Months Forecast

Average 339.31 USD 4.61%

High 381 USD

Low 215 USD

Based on 17 Wall Street analysts offering 12 month price targets forAmgen Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

17 ratings

Buy

Hold

Sell

Based on 17 analysts giving stock ratings to Amgen Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 331.29Support & Resistance

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

282 / 365 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq). It focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.